(Q52895633)

9 May 2018

title

Antiepileptic drug discovery: does mechanism of action matter? (English)

1 reference

9 May 2018

1 reference

Dieter Schmidt

1

1 reference

9 May 2018

publication date

10 May 2011

1 reference

9 May 2018

published in

Epilepsy Behavior

1 reference

9 May 2018

volume

21

1 reference

9 May 2018

issue

4

1 reference

9 May 2018

page(s)

342-343

1 reference

9 May 2018

Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.03.037

The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.03.037

The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.03.037

The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.03.037

Pharmacotherapy of epilepsy: newly approved and developmental agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.03.037

Antiepileptic drug therapy: does mechanism of action matter?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.03.037

Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.03.037

Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.03.037

Modern management of epilepsy: a practical approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.03.037

The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.03.037

New developments in antiepileptic drug resistance: an integrative view

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2011.03.037

10.1016/J.YEBEH.2011.03.037

7 January 2021

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018